Order Article Reprints

Lidbury BA, Kita B, Richardson AM, Lewis DP, Privitera E, Hayward S, de Kretser D, Hedger M. Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity. Diagnostics. 2019; 9(3):79. https://doi.org/10.3390/diagnostics9030079

Lidbury, Brett A., Badia Kita, Alice M. Richardson, Donald P. Lewis, Edwina Privitera, Susan Hayward, David de Kretser, and Mark Hedger. 2019. "Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity" Diagnostics 9, no. 3: 79. https://doi.org/10.3390/diagnostics9030079

Lidbury, B. A., Kita, B., Richardson, A. M., Lewis, D. P., Privitera, E., Hayward, S., de Kretser, D., & Hedger, M. (2019). Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity. Diagnostics, 9(3), 79. https://doi.org/10.3390/diagnostics9030079